Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Sentinel lymph node biopsy in clinically node-negative Merkel cell carcinoma: the Westmead Hospital experience.

Jenkins LN, Howle JR, Veness MJ.

ANZ J Surg. 2019 May;89(5):520-523. doi: 10.1111/ans.15228. Epub 2019 Apr 8.

PMID:
30959572
2.

PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors.

Kakavand H, Rawson RV, Pupo GM, Yang JYH, Menzies AM, Carlino MS, Kefford RF, Howle JR, Saw RPM, Thompson JF, Wilmott JS, Long GV, Scolyer RA, Rizos H.

Clin Cancer Res. 2017 Oct 15;23(20):6054-6061. doi: 10.1158/1078-0432.CCR-16-1688. Epub 2017 Jul 19.

3.

Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma.

Vilain RE, Menzies AM, Wilmott JS, Kakavand H, Madore J, Guminski A, Liniker E, Kong BY, Cooper AJ, Howle JR, Saw RPM, Jakrot V, Lo S, Thompson JF, Carlino MS, Kefford RF, Long GV, Scolyer RA.

Clin Cancer Res. 2017 Sep 1;23(17):5024-5033. doi: 10.1158/1078-0432.CCR-16-0698. Epub 2017 May 16.

4.

Definitive radiotherapy for Merkel cell carcinoma confers clinically meaningful in-field locoregional control: A review and analysis of the literature.

Gunaratne DA, Howle JR, Veness MJ.

J Am Acad Dermatol. 2017 Jul;77(1):142-148.e1. doi: 10.1016/j.jaad.2017.02.015. Epub 2017 May 9. Review.

PMID:
28495499
5.

The value of sentinel lymph node biopsy in Merkel cell carcinoma: reply from the authors.

Gunaratne DA, Howle JR, Veness MJ.

Br J Dermatol. 2016 Sep;175(3):650. doi: 10.1111/bjd.14792. Epub 2016 Jul 31. No abstract available.

PMID:
27476497
6.

Sentinel lymph node biopsy in Merkel cell carcinoma: a 15-year institutional experience and statistical analysis of 721 reported cases.

Gunaratne DA, Howle JR, Veness MJ.

Br J Dermatol. 2016 Feb;174(2):273-81. doi: 10.1111/bjd.14240. Epub 2015 Dec 19. Review.

PMID:
26480031
7.

Merkel cell carcinoma: A case of palliative upper limb amputation in a patient with refractory in-transit metastases.

Gunaratne DA, Howle JR, Veness MJ.

Australas J Dermatol. 2016 May;57(2):e53-6. doi: 10.1111/ajd.12291. Epub 2015 Mar 5.

PMID:
25754425
8.

Outcome of patients with microscopic and macroscopic metastatic nodal Merkel cell carcinoma: an Australian experience.

Howle JR, Veness MJ.

Dermatol Surg. 2014 Jan;40(1):46-51. doi: 10.1111/dsu.12390. Epub 2013 Dec 10.

PMID:
24320201
9.

Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicine.

Wilmott JS, Tembe V, Howle JR, Sharma R, Thompson JF, Rizos H, Lo RS, Kefford RF, Scolyer RA, Long GV.

Mol Cancer Ther. 2012 Dec;11(12):2704-8. doi: 10.1158/1535-7163.MCT-12-0530. Epub 2012 Sep 7.

10.

Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma.

Menzies AM, Haydu LE, Visintin L, Carlino MS, Howle JR, Thompson JF, Kefford RF, Scolyer RA, Long GV.

Clin Cancer Res. 2012 Jun 15;18(12):3242-9. doi: 10.1158/1078-0432.CCR-12-0052. Epub 2012 Apr 24.

11.

Plexiform fibrohistiocytic tumour: morphological changes and challenges in assessment of recurrent and metastatic lesions.

Lynnhtun K, Achan A, Shingde M, Chou S, Howle JR, Sharma R.

Histopathology. 2012 Jun;60(7):1156-8. doi: 10.1111/j.1365-2559.2011.04173.x. Epub 2012 Mar 21. No abstract available.

PMID:
22435737
12.

Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma.

Wilmott JS, Long GV, Howle JR, Haydu LE, Sharma RN, Thompson JF, Kefford RF, Hersey P, Scolyer RA.

Clin Cancer Res. 2012 Mar 1;18(5):1386-94. doi: 10.1158/1078-0432.CCR-11-2479. Epub 2011 Dec 12.

13.

Merkel cell carcinoma metastatic to the transverse colon: disease free after six years - cure or just prolonged remission?

Veness MJ, Howle JR.

Australas J Dermatol. 2011 Nov;52(4):295-7. doi: 10.1111/j.1440-0960.2011.00782.x. Epub 2011 Jun 13.

PMID:
22070707
14.

Merkel cell carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients.

Howle JR, Hughes TM, Gebski V, Veness MJ.

J Am Acad Dermatol. 2012 Jul;67(1):33-40. doi: 10.1016/j.jaad.2011.07.029. Epub 2011 Oct 11.

PMID:
21996296
15.

Metastatic cutaneous squamous cell carcinoma of the scalp.

Howle JR, Morgan GJ, Kalnins I, Palme CE, Veness MJ.

ANZ J Surg. 2008 Jun;78(6):449-53. doi: 10.1111/j.1445-2197.2008.04533.x.

PMID:
18522564

Supplemental Content

Loading ...
Support Center